Peptide Synthesis Market worth $1.41 billion in 2029
The global peptide synthesis market is estimated to expand to a value of USD 1.44 billion in 2029 from USD 0.91 billion in 2024, growing at a CAGR of 9.5%. The rise in biopharmaceutical research and the use of synthetic peptides in vaccine development, such as mRNA vaccines, is likely to fuel market growth. The outsourcing trend for peptide synthesis services by pharmaceutical companies to reduce costs and focus on core competencies is further likely to support market expansion.
The products segment accounted for the largest share of the offerings segment in the peptide synthesis market in 2023.
Based on offerings, the market is segmented into products and services. By-products market is further divided into consumables and instruments. Among these consumables dominated the peptide synthesis market. The consumables segment is further bifurcated into reagents and other consumables. The reagents market is further divided into resins, amino acids, coupling reagents, dyes & fluorescent labeling reagents, deprotection agents, cleavage reagents, and other reagents. The instruments segment is further divided into peptide synthesizers, chromatography equipment, lyophilizers, and others. The peptide synthesizer segment is further divided into automated and manual peptide synthesizers. Technological advancements in the peptide synthesizer and the launch of new products in the market are likely to uplift the segmental growth. In May 2024, Activotec Ltd, launched Activo-Darwin Semi-Automated Peptide Synthesizer, a instrument designed for the synthesis of very high quality peptides.
Peptide synthesis services is anticipated to grow at significant CAGR during the forecast period.
The services segment is further divided into peptide library synthesis, peptide synthesis, peptide purification services, and peptide analysis services. The peptide synthesis segment dominated the services segment. Leading companies such as Bachem, GenScript, and Thermo Fisher Scientific provide a wide range of peptide synthesis services, including custom synthesis, peptide modifications, and large-scale production. The increasing complexity of peptides, with long chains and non-standard amino acids propelled the need of peptide synthesis services contributing towards segmental growth.
Solid-Phase Peptide Synthesis (SPPS) dominated the technique segment in 2023.
Based on technique, the peptide synthesis market is segmented into chemical and biological. The chemical segment is further divided into solid-phase peptide synthesis, solution-phase peptide synthesis, and others. The biological segment is divided into recombinant DNA technology and enzymes. The solid-phase peptide synthesis (SPPS) segment leads the peptide synthesis market, driven by its efficiency, scalability, and extensive use in both research and commercial settings. SPPS facilitates the sequential assembly of peptides on an insoluble resin, enabling fast synthesis and simplified purification.
Cancer segment dominated the technique segment in 2023.
Based on application, the market is divided into therapeutics, diagnostics, and research & development. Therapeutics by indication is further divided into cancer, diabetes, obesity, autoimmune disease, and other disease indications. Therapeutics by molecules is further segmented into peptide-based vaccines, peptide-drug conjugates (PDCs), peptide inhibitors, and other molecules. The cancer segment dominated the therapeutics by indication segment and is anticipated to grow at a significant CAGR during the forecast period. Factors attributable to the growth is growing demand for peptide-based cancer therapies and diagnostics and rise of immunotherapy has further fueled the adoption of peptides in cancer treatment.
Pharmaceutical and Biotechnology companies segment lead the end users segment in 2023.
The peptide synthesis market is segmented by end users into pharmaceutical and biotechnology companies, CDMOS & CROS, academic and research institutes, medical device companies, and hospitals and diagnostic centers. Increased investment in the novel peptide-based therapies and diagnostics is rising demand for peptide synthesis by pharmaceutical and biotechnology companies is one of the major contributing to the dominance of the segment.
North America region dominated the Peptide Synthesis market.
The Peptide Synthesis market is segmented by region into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America dominated the region segment owing to the adoption of advanced technologies, increased investment in the peptide-based therapeutics and presence of leading companies in the region. Asia Pacific region anticipated The Asia-Pacific (APAC) region is witnessing rapid growth in the peptide synthesis market, driven by increasing healthcare investments, expanding pharmaceutical and biotechnology industries, and rising demand for peptide-based therapeutics.
The prominent players operating in the peptide synthesis market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Kaneka Corporation (Japan), GenScript Biotech Corporation (China), and Bachem Holding AG (Switzerland), among others.
Comments
Post a Comment